Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

GUTS - Fractyl Health, Inc. Financial Statements | Finranks

Home

/

GUTS

F

Fractyl Health, Inc. (GUTS)

NGM – Real Time Price. Currency in USD

0.70

-0.00 (-0.46%)

Market open: Aug 12, 2026, 3:07 PM EDT

0.70

-0.00 (-0.26%)

Previous after-hours: Aug 11, 2026, 7:46 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

93K

120K

0

Cost of goods sold

-1M

-727K

-363K

-452K

Gross Profit

-1M

-634K

-243K

-452K

Operating expenses (excl. COGS)

-96M

-93M

-51M

-49M

Operating Income

-97M

-94M

-51M

-49M

Non-operating income, total

-44M

25M

-26M

3M

Pretax income

-141M

-69M

-77M

-46M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-141M

-69M

-77M

-46M

Discontinued operations

0

0

0

0

Net income

-141M

-69M

-77M

-46M

Dilution adjustment

0

0

0

0

Preferred dividends

0

2M

17M

17M

Name

2025

2024

2023

2022

Total assets

121M+12.3%

108M+41.8%

76M+25.0%

61M

Total current assets

88M

72M

36M

52M

Total non-current assets

34M

36M

41M

9M

Total liabilities

112M+40.5%

80M-80.1%

401M+28.1%

313M

Total current liabilities

18M

20M

11M

7M

Total non-current liabilities

94M

60M

390M

306M

Total equity

9M

28M

-325M

-252M

Total liabilities & shareholders' equities

121M

108M

76M

61M

Total debt

62M-1.4%

63M-83.3%

374M+21.8%

307M

Name

2025

2024

2023

2022

Cash from operating activities

-90M

-66M

-43M

-46M

Cash from investing activities

-557K

-2M

-359K

-56K

Cash from financing activities

105M

101M

27M

4M

Free cash flow

-91M-35.1%

-67M-55.8%

-43M+6.7%

-46M